Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text
Drugmakers have long shifted their patents and profits there, as well, to avoid billions of dollars in taxes.
Simplified Text
Drugmakers have long shifted patents and profits to Ireland to avoid billions of dollars in taxes.
Confidence Score
0.900
Claim Maker
The author
Context Type
News Article
Context Details
{
    "amount": "Billions of dollars",
    "reason": "Tax avoidance",
    "location": "Ireland"
}
UUID
9fdb5dae-0e0b-41e9-9b76-5da9b239a443
Vector Index
✗ No vector
Created
September 12, 2025 at 2:46 AM (1 day ago)
Last Updated
September 12, 2025 at 2:46 AM (1 day ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://www.nytimes.com/2025/08/14/health/pharma-tariffs-ireland-taxes.html?campaign_id=9&emc=edit_nn_20250815&instance_id=160603&nl=the-morning&regi_id=122976029&segment_id=203954&user_id=b25c5730c89e0c73f75709d8f1254337
https://www.nytimes.com/2025/08/14/health/pharma-tariffs-ireland-taxes.html?campaign_id=9&emc=edit_nn_20250815&instance_id=160603&nl=the-morning&regi_id=122976029&segment_id=203954&user_id=b25c5730c89e0c73f75709d8f1254337

US drugmakers using Ireland for tax advantages face billions in tariffs from planned 15% levy on European medicines. Companies may shift production to the US, incurring increased costs.

Pharmaceutical Industry
International Trade
Taxation
Ireland
United States
Tariffs
Corporate Tax Avoidance

Similar Claims (0)

Other claims identified as semantically similar to this one.

No similar claims found

This claim appears to be unique in the system.

Claim Management System - MVP